Chen Schor's Net Worth

$11 Million

Estimate Recalculated Nov 11, 2024 02:49AM EST

Who is Chen Schor?

Chen Schor has an estimated net worth of $11 Million. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., SYNTA PHARMACEUTICALS CORP, Karyopharm Therapeutics Inc., BRAINSTORM CELL THERAPEUTICS INC, and EPIX Pharmaceuticals, Inc..

SEC CIK

Chen Schor's CIK is 0001340875

Past Insider Trading and Trends

2006 was Chen Schor's most active year for acquiring shares with 10 total transactions. Chen Schor's most active month to acquire stocks was the month of July. 2023 was Chen Schor's most active year for disposing of shares, totalling 8 transactions. Chen Schor's most active month to dispose stocks was the month of July. 2007 saw Chen Schor paying a total of $49,369.32 for 52,842 shares, this is the most they've acquired in one year. In 2022 Chen Schor cashed out on 148,531 shares for a total of $1,453,179.63, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc. (ACET) Snapshot price: $1.56

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
+35.78%
55.01K
$2.40
-$36,696.00
208.77K
Jan 24
Form 4
-10.53%
-23.21K
$1.39
-$31,935.76
197.23K
Sep 28 - Oct 2
Form 4
—
0
—
—
0
Aug 14
Form 4
+93.47%
85.5K
—
—
176.97K
Jan 24
Form 4
-21.62%
-39.95K
$20.55
-$811,241.79
144.89K
Scheduled
Nov 10
Form 4
-26.45%
-30.00K
$19.05
-$571,488.00
83.42K
Scheduled
Nov 7
Form 4
-18.25%
-25.31K
$18.04
-$456,718.33
113.42K
Scheduled
Nov 2 - Nov 3
Form 4
-17.35%
-21.29K
$14.22
-$302,715.36
101.42K
Oct 4
Form 4
-0.68%
-952.00
$18.00
-$17,136.00
138.74K
Scheduled
Sep 14
Form 4
-35.95%
-78.41K
$17.38
-$1,317,221.72
139.69K
Scheduled
Sep 9 - Sep 13
Form 4
+11.16%
26.71K
$18.25
-$388,506.00
265.97K
Jul 6 - Aug 4
Form 4
+21.77%
26.71K
$14.27
-$303,779.76
149.42K
Feb 14
Form 4
+27.83%
26.71K
$11.69
-$248,856.72
122.71K
Jan 28
Form 4
—
0
—
—
0
Jan 7
Form 4
∞
240K
—
—
240K
Oct 1
Form 4
-9.09%
-16.47K
$10.53
-$173,442.97
164.68K
Scheduled
Jun 16
Form 4
-8.33%
-16.47K
$12.06
-$198,499.28
181.14K
Scheduled
Jun 3
Form 4
-7.69%
-16.47K
$13.45
-$221,435.96
197.61K
Scheduled
May 19
Form 4
-7.14%
-16.47K
$14.22
-$234,221.96
214.07K
Scheduled
May 5
Form 4
-6.67%
-16.47K
$12.01
-$197,675.98
230.54K
Scheduled
Apr 20
Form 4
-6.25%
-16.47K
$13.04
-$214,700.18
247.01K
Scheduled
Apr 6
Form 4
-2.98%
-16.47K
$12.76
-$211,639.80
536.85K
Scheduled
Mar 30
Form 4/A
-19.35%
-135.39K
$15.36
-$252,558.18
564.48K
Scheduled
Jan 22 - Mar 16
Form 4/A
-24.91%
-8.65K
—
—
26.07K
Oct 23
Form 4
-2.83%
-16.47K
$15.36
-$252,558.18
564.48K
Scheduled
Mar 16
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Jan 13
Form 4
-10.66%
-8.65K
—
—
72.5K
Oct 23
Form 4
—
0
—
—
0
Sep 17
Form 4
+105.85%
344K
—
—
669K
Dec 6
Form 4
—
0
—
—
0
Feb 27
Form 4
-50.27%
-2.24M
—
—
2.21M
Jul 6 - Nov 5
Form 4
+0.11%
2K
$8.95
$17,906.60
1.89M
Apr 16
Form 4
+0.11%
2K
$9.36
$18,724.20
1.89M
Apr 11
Form 4
+0.11%
2K
$8.46
$16,914.80
1.89M
Apr 10
Form 3
—
0
—
—
0
No matching records found

SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $243.89

Former President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+333.77%
28.61K
$9.48
-$135,090.00
37.18K
Jul 22
Form 4
—
0
—
—
0
Oct 2
Form 4
—
0
—
—
0
Sep 16
Form 4
+100.00%
150K
—
—
300K
Jun 5
Form 4
∞
150K
—
—
150K
Dec 8
Form 3
—
0
—
—
0
No matching records found

Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Nov 25
Form 3
—
0
—
—
0
No matching records found

BRAINSTORM CELL THERAPEUTICS INC (BCLI) Snapshot price: $0.2803

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
125.56K
Oct 24
Form 4
+1.62%
2K
—
—
125.56K
Nov 30
Form 4
+1.65%
2K
—
—
123.56K
Nov 10
Form 4
+97.47%
60K
—
—
121.56K
May 3
Form 4/A
∞
923.37K
—
—
923.37K
Oct 21
Form 4
∞
923.37K
—
—
923.37K
Aug 22
Form 3
—
0
—
—
0
No matching records found

EPIX Pharmaceuticals, Inc. No price found

Chief Business Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.89%
5.46K
$0.46
-$1,515.24
145.72K
Feb 25
Form 4
+36.22%
37.3K
$1.03
-$27,195.09
140.26K
Dec 31
Form 4
—
0
—
—
0
Feb 25
Form 4
+18.44%
16.03K
$3.08
$49,369.32
102.97K
Oct 19
Form 4
—
0
—
—
0
Feb 5
Form 4
+3.57%
3K
$0.98
$2,940.00
86.94K
Nov 28
Form 4
+21.76%
15K
$0.98
$14,700.00
83.94K
Nov 2
Form 4
—
0
—
—
0
Aug 18
Form 4
∞
68.94K
—
—
68.94K
Aug 16
Form 3
—
0
—
—
0
No matching records found